These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 20439795)

  • 1. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
    Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
    Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.
    Oberlander TF; Reebye P; Misri S; Papsdorf M; Kim J; Grunau RE
    Arch Pediatr Adolesc Med; 2007 Jan; 161(1):22-9. PubMed ID: 17199063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal serotonin reuptake inhibitor antidepressant exposure, SLC6A4 genetic variations, and cortisol activity in 6-year-old children of depressed mothers: A cohort study.
    Zusman EZ; Chau CMY; Bone JN; Hookenson K; Brain U; Glier MB; Grunau RE; Weinberg J; Devlin AM; Oberlander TF
    Dev Psychobiol; 2023 Nov; 65(7):e22425. PubMed ID: 37860904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children.
    Lupattelli A; Wood M; Ystrom E; Skurtveit S; Handal M; Nordeng H
    J Am Acad Child Adolesc Psychiatry; 2018 Mar; 57(3):200-208. PubMed ID: 29496129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
    Rotem-Kohavi N; Oberlander TF
    Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
    Oberlander TF; Bonaguro RJ; Misri S; Papsdorf M; Ross CJ; Simpson EM
    Mol Psychiatry; 2008 Jan; 13(1):65-73. PubMed ID: 17519929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
    Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age.
    Weikum WM; Brain U; Chau CM; Grunau RE; Boyce WT; Diamond A; Oberlander TF
    Front Cell Neurosci; 2013; 7():180. PubMed ID: 24130516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure.
    Oberlander TF; Grunau R; Mayes L; Riggs W; Rurak D; Papsdorf M; Misri S; Weinberg J
    Early Hum Dev; 2008 Oct; 84(10):689-97. PubMed ID: 18639992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior.
    Hanley GE; Brain U; Oberlander TF
    Pediatr Res; 2015 Aug; 78(2):174-80. PubMed ID: 25897539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal serotonin signaling: setting pathways for early childhood development and behavior.
    Oberlander TF
    J Adolesc Health; 2012 Aug; 51(2 Suppl):S9-16. PubMed ID: 22794534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
    Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H
    JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Prenatal Selective Serotonin Reuptake Inhibitor Antidepressant Exposure and Maternal Mood on Physical Activity, Dietary Intake, and Markers of Adiposity at Age 6 Years.
    Hutchison SM; Mâsse LC; Glier MB; Brain U; Devlin AM; Oberlander TF
    J Dev Behav Pediatr; 2019 May; 40(4):266-274. PubMed ID: 30950906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth.
    Devlin AM; Brain U; Austin J; Oberlander TF
    PLoS One; 2010 Aug; 5(8):e12201. PubMed ID: 20808944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
    Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
    BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.
    Misri S; Reebye P; Kendrick K; Carter D; Ryan D; Grunau RE; Oberlander TF
    Am J Psychiatry; 2006 Jun; 163(6):1026-32. PubMed ID: 16741203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.